ImPACT: During the ImPACT program, the childhood cancer survivor and at least one parent collaborates on:
1. Becoming aware of the child's core strengths and difficulties
2. Helping the child to be optimally responsive to the guidance of the parent(s), and
3. Creating compensatory strategies to respond to real-world manifestations of the child's difficulties and helping the child implement these strategies at home.
Study summary
The aim of the present pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of a novel, context-sensitive neuropsychological rehabilitation intervention for childhood cancer survivors and their families.
Eligibility
Sex
ALL
Min age
10 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria:
* Cancer diagnosis of a leukemia, lymphoma, or central nervous system tumor
* Completed primary treatment at least 6 months ago
* Not terminally ill
* Attend school
* Living with one or more parents who speak Danish and are willing to co-participate
* Screened as having parent-reported cognitive and/or neurobehavioral impairment
Exclusion Criteria:
• Confounding diagnosed or suspected psychiatric or medical condition unrelated to the cancer or its treatment that might contribute to cognitive or neurobehavioral impairment
Primary outcome measure(s)
Parent-reported neurobehavioral functioning — Baseline (T1) to after last session (approximately 9 weeks later: Post-intervention, T3) The parent-report screening version of the Behavior Rating Inventory of Executive Function 2nd Edition (BRIEF-2). 12 items: answer format range: 1-3; total score range: 12-36. Higher score indicates more impairment.
Parent-reported cognitive functioning — Baseline (T1) to after last session (approximately 9 weeks later: Post-intervention, T3) The parent-report version of the Pediatric Perceived Cognitive Function (PedsPCF) Short Form. 7 items: answer format range 1-5; total score range: 7-35. Lower score indicates more impairment.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
